Bamlanivimab improves hospitalization and mortality rates in patients with COVID-19: A systematic review and meta-analysis

Detalles Bibliográficos
Autores principales: Zuo, Ling, Ao, Guangyu, Wang, Yushu, Gao, Ming, Qi, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438996/
https://www.ncbi.nlm.nih.gov/pubmed/34534563
http://dx.doi.org/10.1016/j.jinf.2021.09.003
_version_ 1783752451001679872
author Zuo, Ling
Ao, Guangyu
Wang, Yushu
Gao, Ming
Qi, Xin
author_facet Zuo, Ling
Ao, Guangyu
Wang, Yushu
Gao, Ming
Qi, Xin
author_sort Zuo, Ling
collection PubMed
description
format Online
Article
Text
id pubmed-8438996
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-84389962021-09-14 Bamlanivimab improves hospitalization and mortality rates in patients with COVID-19: A systematic review and meta-analysis Zuo, Ling Ao, Guangyu Wang, Yushu Gao, Ming Qi, Xin J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-02 2021-09-14 /pmc/articles/PMC8438996/ /pubmed/34534563 http://dx.doi.org/10.1016/j.jinf.2021.09.003 Text en © 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Zuo, Ling
Ao, Guangyu
Wang, Yushu
Gao, Ming
Qi, Xin
Bamlanivimab improves hospitalization and mortality rates in patients with COVID-19: A systematic review and meta-analysis
title Bamlanivimab improves hospitalization and mortality rates in patients with COVID-19: A systematic review and meta-analysis
title_full Bamlanivimab improves hospitalization and mortality rates in patients with COVID-19: A systematic review and meta-analysis
title_fullStr Bamlanivimab improves hospitalization and mortality rates in patients with COVID-19: A systematic review and meta-analysis
title_full_unstemmed Bamlanivimab improves hospitalization and mortality rates in patients with COVID-19: A systematic review and meta-analysis
title_short Bamlanivimab improves hospitalization and mortality rates in patients with COVID-19: A systematic review and meta-analysis
title_sort bamlanivimab improves hospitalization and mortality rates in patients with covid-19: a systematic review and meta-analysis
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438996/
https://www.ncbi.nlm.nih.gov/pubmed/34534563
http://dx.doi.org/10.1016/j.jinf.2021.09.003
work_keys_str_mv AT zuoling bamlanivimabimproveshospitalizationandmortalityratesinpatientswithcovid19asystematicreviewandmetaanalysis
AT aoguangyu bamlanivimabimproveshospitalizationandmortalityratesinpatientswithcovid19asystematicreviewandmetaanalysis
AT wangyushu bamlanivimabimproveshospitalizationandmortalityratesinpatientswithcovid19asystematicreviewandmetaanalysis
AT gaoming bamlanivimabimproveshospitalizationandmortalityratesinpatientswithcovid19asystematicreviewandmetaanalysis
AT qixin bamlanivimabimproveshospitalizationandmortalityratesinpatientswithcovid19asystematicreviewandmetaanalysis

Ejemplares similares